A61P 17 - Drugs for dermatological disorders

Patents for A61P 17 - Drugs for dermatological disorders (106,455)
11/2002
11/28/2002	WO2002070563A3 Nuclear hormone receptor ligand binding domain
11/28/2002	WO2002070532A3 C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses
11/28/2002	WO2002066636A3 T cell receptor variants expressed in mesenchymal cells and uses thereof
11/28/2002	WO2002047711A3 Modulators of activity of g-protein-coupled receptor kinases
11/28/2002	WO2002044153A8 4-6-diphenyl pyridine derivatives as antiinflammatory agents
11/28/2002	WO2002035235A3 Net as regulator of angiogenic expression
11/28/2002	WO2002024924A3 Protein phosphatases
11/28/2002	WO2002020002A3 A method for treating allergies
11/28/2002	WO2002015977A3 Methods and compositions for treating ige-related disease using nnt-1 inhibitors
11/28/2002	WO2002008255A3 Cell cycle proteins and mitosis-associated molecules
11/28/2002	WO2001081415A3 Parathyroid hormone and parathyroid hormone-related protein antagonists
11/28/2002	WO2001018021A9 B7-like polynucleotides, polypeptides, and antibodies
11/28/2002	WO2000050070A9 Preparation for the treatment of pigmentation disorders
11/28/2002	US20020178459 Genetically engineered mammal for use in the treatment of muscle and liver disorders
11/28/2002	US20020178135 Image searching system and image searching method, and a recording medium storing an image searching program
11/28/2002	US20020177717 Compounds and methods for the inhibition of the expression of VCAM-1
11/28/2002	US20020177706 Rheumatic diseases; antiarthritic agents; antitumor agents
11/28/2002	US20020177618 ERK (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
11/28/2002	US20020177609 Fatty alcohol drug conjugates
11/28/2002	US20020177605 3-substituted isoquinolin-1-yl derivatives
11/28/2002	US20020177601 Inhibit the signal transduction by tyrosine kinases; e.g. 4-(3-chloro-4-fluorophenylamino)-6-(3-(4-(methoxycarbonyl-methyl)-1 -piperazinyl)propyloxy)-7-methoxyquinazoline; use such as antitumor agent
11/28/2002	US20020177600 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic
11/28/2002	US20020177586 Method for treating fibrotic diseases or other indications ID
11/28/2002	US20020177213 Tissue plasminogen activator-like protease
11/28/2002	US20020176903 Comprising an olive plant extract
11/28/2002	US20020176891 Topical gel delivery system
11/28/2002	US20020176887 Methods of delivery of cetyl myristoleate
11/28/2002	US20020176885 Given concentration of halide-comprising salts such as sodium chloride; nonirritating antiseptic; can be used in eyes
11/28/2002	US20020176846 Storage stable powder compositions of interleukin-4 receptor
11/28/2002	DE10125145A1 New C-furanyl- or C-thienyl-methylamine derivatives, useful e.g. for treating arrhythmia, emesis, inflammation, cardiovascular or neurodegenerative disease, asthma, glaucoma or especially pain
11/28/2002	DE10123586A1 New 3,5-diamino-1,2,4-triazole derivatives, are cyclin dependent kinase inhibitors useful for treating e.g. cancer, autoimmune, cardiovascular or neurodegenerative diseases or viral infections
11/28/2002	DE10122140A1 Rekombinante Fusionsproteine und deren Trimere Recombinant fusion proteins and their trimers
11/28/2002	CA2448045A1 Identifying parasitic fungi of the organism, and treatment thereof
11/28/2002	CA2447231A1 Methods for inhibiting angiogenesis
11/28/2002	CA2447023A1 Conjugates activated by cell surface proteases and therapeutic uses thereof
11/28/2002	CA2446734A1 Antibodies against tumor necrosis factor delta (april)
11/28/2002	CA2446049A1 The use of a gatran for the manufacture of a medicament for the treatment of pulmonary fibrosis
11/28/2002	CA2445631A1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	CA2444955A1 Inactivation of genes of the mep pathway
11/27/2002	EP1260587A2 Tyrosyl tRNA synthetase
11/27/2002	EP1260509A1 Uses of tocopherol esters
11/27/2002	EP1260227A1 Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative bacteria, potential pathogenic gram-positive bacteria
11/27/2002	EP1260211A1 Skin preparations for external use
11/27/2002	EP1260210A1 Squalane containing ultra fine particles of burning residue of carbon and method for producing the same
11/27/2002	EP1259626A2 Materials and methods involving hybrid vascular endothelial growth factor dnas and proteins and screening methods for modulators
11/27/2002	EP1259621A2 Lipid metabolism enzymes
11/27/2002	EP1259615A1 Human antibodies against eotaxin and their use
11/27/2002	EP1259611A2 G-protein coupled receptors
11/27/2002	EP1259598A2 Stimulation of cartilage growth with agonists of the non-proteolytically activated thrombin receptor
11/27/2002	EP1259595A2 Integrin antagonists
11/27/2002	EP1259544A2 Heterologous polypeptide of the tnf family
11/27/2002	EP1259527A1 35 human secreted proteins
11/27/2002	EP1259514A2 3-(pyrolyllactone)-2-indolinone compounds as kinase inhibitors
11/27/2002	EP1259512A1 Pteridine compounds for the treatment of psoriasis
11/27/2002	EP1259510A2 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers
11/27/2002	EP1259508A1 Novel biarylcarboxamides
11/27/2002	EP1259504A1 Pyrazole ether derivatives as anti-inflammatory/analgesic agents
11/27/2002	EP1259499A1 Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors
11/27/2002	EP1259494A1 Aryloxyacetic acids for diabetes and lipid disorders
11/27/2002	EP1259488A1 Ortho-sulfonamido aryl hydroxamic acids, process for their preparation and their use as matrix metalloproteinase inhibitors
11/27/2002	EP1259487A1 2-amino-nicotinamide derivatives and their use as vegf-receptor tyrosine kinase inhibitors
11/27/2002	EP1259477A1 Aminoadamantane derivatives as therapeutic agents
11/27/2002	EP1259269A1 Agent for the treatment of wounds
11/27/2002	EP1259247A1 DNA ENCODING HUMAN ACID-SENSING ION CHANNEL BNaC4 (ASIC4)
11/27/2002	EP1259241A1 The use of scopolamine salts
11/27/2002	EP1259240A2 Agents, such as nicotinamide or cadpr for the treatment of skin disorders
11/27/2002	EP1259236A1 Tyrosine kinase inhibitors
11/27/2002	EP1259235A1 Tyrosine kinase inhibitors
11/27/2002	EP1259234A1 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy
11/27/2002	EP1259120A2 Method for isolating sponge collagen and producing nanoparticulate collagen, and the use thereof
11/27/2002	EP1259114A1 A topical, non-cytotoxic, antimicrobial hydrogel with thixotropic properties
11/27/2002	EP1083929A4 The use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals
11/27/2002	EP1073639B1 Quinoline derivatives
11/27/2002	EP1059931B1 Utilization of cd137 in order to promote the proliferation of peripheral monocytes
11/27/2002	EP1000035B1 Substituted 6-phenylphenanthridines
11/27/2002	EP0975223A4 In-situ generation of zinc pyrithione
11/27/2002	EP0954280B1 Use of an extract of terminalia catappa
11/27/2002	EP0783303B1 Use of aromatic halides for treating mammalian cell proliferation
11/27/2002	EP0777471B1 Inhibition of leukotriene biosynthesis with urea derivatives
11/27/2002	CN1382146A Imidazole derivatives asphosphodiesterase VII inhibitors
11/27/2002	CN1382144A Heteroalkylamino-substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002	CN1382143A Inhibitors of alpha L beta 2 mediated cell adhesion
11/27/2002	CN1382142A Alkylamino substituted bicyclic nitrogen heterocycles as inhibitors of P38 protein kinase
11/27/2002	CN1382137A Thtrahydrothiopy 2,3-diazanaphthylaone derivatives as PDE inhibitors
11/27/2002	CN1382136A N-heterocyclic derivatives as NOS inhibitors
11/27/2002	CN1382124A Bicycle androgen and progesterone receptor modulator compounds and methods
11/27/2002	CN1382122A Pyrrole derivatives as phosphodiesterase VII inhibitors
11/27/2002	CN1382121A C16 unsaturated FP-selective prostaglandins analogs
11/27/2002	CN1382118A Biocyclic amino acids aspharmaceutical agents
11/27/2002	CN1382052A Use of dipyridazole or mopidamol in the manufacture of a medicament for treatment and prevention of fibrin-dependent microcirculation disorders
11/27/2002	CN1381269A Plaster for treating inflammations and sores
11/27/2002	CN1381267A Wound spray for treating burn
11/27/2002	CN1381264A Radiation shielding medicine for skin
11/27/2002	CN1381262A Face-beautifying sanility-delaying medical wine for women and its preparing process
11/27/2002	CN1381251A Ointment for treating burn and scald and its preparing process
11/27/2002	CN1381249A Chinese patent medicine for treating venereal disease and puzzle dermatopathy
11/27/2002	CN1094765C External-use burn ointment
11/26/2002	US6486377 Biodegradation
11/26/2002	US6486322 Azaindole derivatives, process for their preparation, and their use as antitumor agents
11/26/2002	US6486212 Semifluorinated alkanes and the use thereof

1 ... 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 ... 1065